Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Research Area
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

BAY-069 is an inhibitor of branched-chain amino acid transaminase 1 (BCAT1) and BCAT2 (IC50s = 31 and 153 nM, respectively).1 It is selective for BCAT1 and BCAT2 over a panel of 77 enzymes, receptors, and transporters at 10 µM. BAY-069 increases the levels of branched-chain amino acids (BCAAs) in U87MG brain and MDA-MB-231 breast cancer cells (IC50s = 358 and 874 nM, respectively) but not in the presence of human serum albumin (HSA) or BSA (IC50s = >50 µM for both).
WARNING This product is not for human or veterinary use.
1. BAY-